OR Manager Conference (formerly Managing Today’s OR Suite), brings together more than 1, 400 managers and directors involved in leading the surgical suite for 3 days of continuing education and networking opportunities. The conference builds on the content developed in each issue of OR Manager, providing you with a live learning experience. Earn CEs, AEUs, and explore new technologies with solution providers.
OR Manager Conference provides you with plenty of opportunities to earn contact hours throughout the three days you will spend in New Orleans!Learn More
Editor’s Note Hospitals should consider adopting a care bundle approach to improve outcomes for emergency laparotomy patients, this study finds. In this analysis of 14,809 patients in 28 hospitals in the UK, reduction in unadjusted mortality (from 9.8% to 8.3%) and length of stay (from 20.1 days to 18.9 days) were seen after implementation of […]
The post Effect of care bundle on emergency laparotomy outcomes appeared first on OR Manager.
Editor’s Note The Joint Commission on March 20 announced that time is running out for organizations to submit applications for the 2019 Pioneers in Quality Proven Practices Collection. Applications must be submitted online by April 5. Among topics of interest: Demonstrating improvements in clinical performance or outcomes using electronic clinical quality measures (eCQMs). Integrating clinical […]
The post Joint Commission: eCQM Proven Practices must be submitted by April 5 appeared first on OR Manager.
Editor’s Note In this study, having elective coronary artery bypass grafting (CABG) surgery under inhaled (ie, desflurane, isoflurane, or sevoflurane) anesthesia did not result in significantly fewer deaths than total intravenous (IV) anesthesia, though inhaled agents have cardioprotective effects. A total of 5,400 patients at 36 centers in 13 countries were randomly assigned to inhaled […]
The post Inhaled anesthetics vs total IV anesthesia for CABG surgery appeared first on OR Manager.
Editor’s Note The Food & Drug Administration (FDA) on March 19 issued warning letters to two breast implant manufacturers (Mentor Worldwide LLC of Irvine, California, and Sientra, Inc of Santa Barbara, California) for failing to comply with post-approval study requirements. All manufacturers of approved silicone gel-filled implants are required to conduct post-approval studies to further […]
The post FDA issues warning letters to two breast implant manufacturers appeared first on OR Manager.